Cardinal Health (NYSE:CAH – Get Rating) had its price objective lowered by stock analysts at Morgan Stanley from $74.00 to $70.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 32.33% from the stock’s previous close.
A number of other research analysts have also weighed in on the stock. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, May 6th. TheStreet lowered shares of Cardinal Health from a “c+” rating to a “d+” rating in a research report on Thursday, May 5th. Barclays lowered shares of Cardinal Health from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $70.00 to $64.00 in a research report on Thursday, May 26th. Finally, Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $55.00 to $68.00 in a research report on Wednesday, May 18th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $60.11.
Governments across the globe want to go “All Electric” by 2035. There’s one rare metal that could cripple these plans. Without it, going green is impossible. And that’s why there’s a modern-day gold-rush for this rare metal.
Cardinal Health stock opened at $52.90 on Thursday. The firm has a market cap of $14.41 billion, a price-to-earnings ratio of 8.06, a P/E/G ratio of 7.27 and a beta of 0.82. The company has a debt-to-equity ratio of 5.33, a current ratio of 1.08 and a quick ratio of 0.54. Cardinal Health has a fifty-two week low of $45.85 and a fifty-two week high of $64.53. The firm has a fifty day moving average price of $54.31 and a two-hundred day moving average price of $54.96.
Cardinal Health (NYSE:CAH – Get Rating) last released its earnings results on Thursday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.54 by ($0.09). The firm had revenue of $44.84 billion for the quarter, compared to analyst estimates of $43.20 billion. Cardinal Health had a positive return on equity of 155.24% and a negative net margin of 0.54%. The firm’s revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.53 EPS. As a group, sell-side analysts expect that Cardinal Health will post 5.18 earnings per share for the current year.
A number of large investors have recently bought and sold shares of CAH. State Street Corp grew its stake in Cardinal Health by 12.2% during the fourth quarter. State Street Corp now owns 21,345,022 shares of the company’s stock worth $1,109,396,000 after buying an additional 2,327,008 shares during the last quarter. CFS Investment Advisory Services LLC grew its stake in Cardinal Health by 6,455.0% during the first quarter. CFS Investment Advisory Services LLC now owns 1,513,493 shares of the company’s stock worth $27,000 after buying an additional 1,490,404 shares during the last quarter. Invesco Ltd. grew its stake in Cardinal Health by 29.6% during the fourth quarter. Invesco Ltd. now owns 5,674,226 shares of the company’s stock worth $292,167,000 after buying an additional 1,295,582 shares during the last quarter. Equity Investment Corp bought a new stake in Cardinal Health during the first quarter worth about $63,473,000. Finally, BlackRock Inc. grew its stake in Cardinal Health by 5.0% during the first quarter. BlackRock Inc. now owns 23,108,919 shares of the company’s stock worth $1,310,275,000 after buying an additional 1,109,613 shares during the last quarter. 84.26% of the stock is owned by hedge funds and other institutional investors.
Cardinal Health Company Profile (Get Rating)
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should you invest $1,000 in Cardinal Health right now?
Before you consider Cardinal Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Cardinal Health wasn’t on the list.
While Cardinal Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
